Trial Profile
Statins and lupus: effects of statins on clinical lupus parameters, serological markers and toll-like receptors.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Systemic lupus erythematosus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 23 Sep 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 23 Sep 2009 Actual initiation date (Sep 2007) added as reported by ClinicalTrials.gov.
- 23 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.